Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborators:
National Comprehensive Cancer Network
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00834678
First received: January 31, 2009
Last updated: May 12, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |